OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300243$18.1656

Shandong Ruifeng Chemical Co Ltd

Commodity ChemicalsVerified

The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.85, indicating a balanced mix of debt and equity financing. Its liquidity position is assessed as medium, with a current ratio of 1.81, suggesting it can cover short-term obligations but with limited buffer. The price-to-book ratio of 3.99 and price-to-tangible-book ratio of 3.99 indicate that the company's market value is significantly higher than its book value, potentially reflecting market expectations of future growth or intangible assets. Profitability metrics show a weak performance relative to industry norms. The return on equity (ROE) of 2.65% and return on assets (ROA) of 1.31% are below the typical thresholds for the Commodity Chemicals industry, which often requires higher returns to justify capital deployment. The company's gross profit margin of 15.1% (calculated from gross profit of 297.15 million CNY on revenue of 1.97 billion CNY) is in line with industry medians, but its operating margin of 1.84% (36.21 million CNY on 1.97 billion CNY revenue) is notably low, indicating inefficiencies in cost control or pricing power. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, it operates as a single business unit focused on commodity chemicals, with no diversification across product lines or markets. This lack of diversification increases exposure to domestic economic cycles and regulatory shifts in the Chinese chemical industry. The company's growth trajectory is modest. Based on the current fiscal year outlook, revenue is expected to remain flat, with no significant growth anticipated in the next fiscal year. Historical revenue data shows a stable but non-expanding trend, with the most recent reported revenue at 1.97 billion CNY. The company's capital expenditure of -33.67 million CNY suggests a reduction in investment, which may signal a focus on cost containment rather than expansion. Risk factors include a medium liquidity risk due to a current ratio of 1.81 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. However, the company's operating cash flow of 133.04 million CNY is insufficient to cover its long-term debt of 969.28 million CNY, which could become a concern if cash flow deteriorates. Recent events include no material filings or transcripts in the last quarter. The company's 10-K and annual reports do not indicate any significant legal or regulatory issues, but its exposure to the Chinese chemical industry means it is subject to environmental and safety regulations that could impact operations.

30-day price · 300243(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyShandong Ruifeng Chemical Co Ltd
Ticker300243.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shandong Ruifeng Chemical Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.85, indicating a balanced mix of debt and equity financing. Its liquidity position is assessed as medium, with a current ratio of 1.81, suggesting it can cover short-term obligations but with limited buffer. The price-to-book ratio of 3.99 and price-to-tangible-book ratio of 3.99 indicate that the company's market value is significantly higher than its book value, potentially reflecting market expectations of future growth or intangible assets. Profitability metrics show a weak performance relative to industry norms. The return on equity (ROE) of 2.65% and return on assets (ROA) of 1.31% are below the typical thresholds for the Commodity Chemicals industry, which often requires higher returns to justify capital deployment. The company's gross profit margin of 15.1% (calculated from gross profit of 297.15 million CNY on revenue of 1.97 billion CNY) is in line with industry medians, but its operating margin of 1.84% (36.21 million CNY on 1.97 billion CNY revenue) is notably low, indicating inefficiencies in cost control or pricing power. Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, it operates as a single business unit focused on commodity chemicals, with no diversification across product lines or markets. This lack of diversification increases exposure to domestic economic cycles and regulatory shifts in the Chinese chemical industry. The company's growth trajectory is modest. Based on the current fiscal year outlook, revenue is expected to remain flat, with no significant growth anticipated in the next fiscal year. Historical revenue data shows a stable but non-expanding trend, with the most recent reported revenue at 1.97 billion CNY. The company's capital expenditure of -33.67 million CNY suggests a reduction in investment, which may signal a focus on cost containment rather than expansion. Risk factors include a medium liquidity risk due to a current ratio of 1.81 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. However, the company's operating cash flow of 133.04 million CNY is insufficient to cover its long-term debt of 969.28 million CNY, which could become a concern if cash flow deteriorates. Recent events include no material filings or transcripts in the last quarter. The company's 10-K and annual reports do not indicate any significant legal or regulatory issues, but its exposure to the Chinese chemical industry means it is subject to environmental and safety regulations that could impact operations.
Key takeaways
  • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.85.
  • Profitability is weak, with ROE and ROA below industry norms.
  • Revenue is concentrated in China, with no international diversification.
  • Growth is expected to remain flat, with no significant expansion in the next fiscal year.
  • Liquidity is medium, with a current ratio of 1.81 and a negative net cash position after debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.97B
Gross profit$297.2M
Operating income$36.2M
Net income$30.3M
R&D
SG&A
D&A
SBC
Operating cash flow$133.0M
CapEx-$33.7M
Free cash flow$60.6M
Total assets$2.31B
Total liabilities$1.17B
Total equity$1.14B
Cash & equivalents
Long-term debt$969.3M
Valuation
Market price$18.16
Market cap$4.56B
Enterprise value$5.53B
P/E150.3
Reported non-GAAP P/E
EV/Revenue2.8
EV/Op income152.7
EV/OCF41.5
P/B4.0
P/Tangible book4.0
Tangible book$1.14B
Net cash-$969.3M
Current ratio1.8
Debt/Equity0.8
ROA1.3%
ROE2.6%
Cash conversion4.4%
CapEx/Revenue-1.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300243Activity
Op margin1.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.5%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin15.1%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity85.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 02:07 UTCJob: cdbc126c